Xconomy National

Archives

by in

Entry	Author	Date	Location
Life Sciences VC Investing Up in Dollar Value, Down in Deal Volume	Arlene Weintraub	02/07/12	New York
Radius Health Seeks $86M IPO	Arlene Weintraub	02/07/12	Boston
Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M	Bruce V. Bigelow	02/07/12	San Diego
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects	Arlene Weintraub	02/06/12	National
Calling All Boston-Area Marketing Mavens…	Rebecca Zacks	02/03/12	Boston
San Diego Life Sciences Roundup: Amylin, Optimer, and the Economy	Bruce V. Bigelow	02/03/12	San Diego
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News	Erin Kutz	02/03/12	Boston
Wayne State Hires Former Pharma Exec to Lead Tech Commercialization Efforts	Sarah Schmid	02/02/12	Detroit
San Diego Life Sciences Strengthened in Recession, Outpacing Nation	Bruce V. Bigelow	02/01/12	San Diego
Flagship Ventures Plans to Open Michigan Office	Sarah Schmid	02/01/12	Detroit
Vertex’s Big Day Felt Like Moon Landing, Seattle Researcher Says	Luke Timmerman	02/01/12	Boston
Avila, iRobot, Verastem, Illume, & More Boston Deal News	Erin Kutz	02/01/12	Boston
Vertex Gets FDA Go-Ahead To Sell New Cystic Fibrosis Drug	Luke Timmerman	01/31/12	Boston
Optimer, Following Pfizer’s Playbook, Has Big Plans for Antibiotic	Luke Timmerman	01/31/12	San Diego
Four Themes to Watch in Personalized Medicine	Jonathan Sheffi	01/30/12	San Francisco
Gates, 13 Pharmas Join $785B Push for Neglected Diseases	Luke Timmerman	01/30/12	Seattle
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis	Arlene Weintraub	01/30/12	Boston
Vision Without Execution is Hallucination	Lisa Suennen	01/30/12	San Francisco
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel	Luke Timmerman	01/30/12	Seattle
Never Back Smug: A Lesson for Life Sciences From Newt Gingrich	Luke Timmerman	01/30/12	National
ConforMIS Adds $89M to Expand Sales, Manufacturing, Technology	Erin Kutz	01/30/12	Boston
Amylin, Alkermes Win FDA Approval of Once-Weekly Diabetes Drug	Luke Timmerman	01/27/12	National
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall	Luke Timmerman	01/27/12	Boston
2012 Venture Outlook: Some Bright Spots and Some Gloom	Bruce V. Bigelow	01/27/12	National
OncoGenex Stays in Prostate Cancer Fray, After J&J, Medivation	Luke Timmerman	01/27/12	Seattle
Why Biogen Idec Got Out of the Corporate VC Business	Luke Timmerman	01/27/12	Boston
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers	Erin Kutz	01/27/12	Boston
Verastem Bucks the Trend, Raises $55M in IPO	Luke Timmerman	01/26/12	Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere	Luke Timmerman	01/26/12	Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event	Arlene Weintraub	01/26/12	Boston
Page 1 of 181	next page »